Presented at #ASCO26:
Among patients with previously treated metastatic pancreatic ductal adenocarcinoma, the RAS(ON) inhibitor daraxonrasib led to significantly longer overall survival and progression-free survival than chemotherapy. Full phase 3 RASolute 302 trial results: https://t.co/xwLWBZYRzq
@ASCO
I remember when the Human Genome Project was underway, Venter led the private effort to get it done asap, in contrast with the NIH who was taking forever
Respect, and Rest in Peace J. Craig Venter
Online now!✨Founded by the Dutch, German, Nordic and British aging research societies, the European Federation for Aging Research (EFAR) has been launched to bring together aging researchers across Europe https://t.co/P7LjD57dF0
The next breakthroughs in biological AI will be shaped by the datasets we build now.
We’re planning an Impetus Grants @impetusgrants round to fund shared, AI-enabling biological datasets.
Learn more and contribute: https://t.co/pCQFD4hOSI
Announced by the ERC today (really bad news for science!!! It starts in Europe but will affect everybody) Because the REVIEWING LOAD is so bad, if your application fails you may need to wait mulitple years (>3?!?) until you can submit again!
The ERC is the lifeline of the leading labs in Europe, so many research programs will be terminated (just no other sources to compensate).
The letter from the ERC says “the only way is to reduce applications” (highlighted in the picture below) No!!!
It's the wrong direction. Use AI to assist review. It’s not perfect (yet), but it allows more proposals to be evaluated, and it could support, not replace, human reviewers.
surprising how rare being clear + direct is
being willing to call out the elephant, state clearly what you want or think, without emotion is a superpower + accelerant